Literature DB >> 20198687

The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.

Adam W G Alani1, Deepa A Rao, Ron Seidel, Jian Wang, Jim Jiao, Glen S Kwon.   

Abstract

The effect of novel surfactants on the aqueous solubility and the permeability of paclitaxel across a Caco-2 cell monolayer were examined in this work. The solubility and permeability of paclitaxel was evaluated in the presence of four soft surfactants (SS) KXN441, KXN424, KXN437, and KXN 337 and Solutol HS15. All surfactants increased the aqueous solubility of paclitaxel. Caco-2 cell membrane integrity in the presence of SS and Solutol HS15 was assessed by mannitol permeability and LDH release. All surfactants were tested at 0.5x CMC, 5x CMC and 1.5 mM concentrations. The effect of SSs on paclitaxel permeability was concentration dependent. At all concentrations tested, KXN 441 and Solutol HS 15 showed partially inhibition of drug efflux with no discernable change in mannitol permeability or cytotoxicity as observed with LDH release. At these concentrations, other SSs exhibited some partial efflux inhibition along with compromised membrane integrity and increasing mannitol permeability. In conclusion, all SSs were able to increase the aqueous solubility and permeability of paclitaxel across Caco-2 cells monolayer. However, KXN441 and Solutol HS15 were able to enhance paclitaxel permeability across Caco-2 monolayer without cytotoxicity. (c) 2010 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20198687     DOI: 10.1002/jps.22111

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

Review 1.  Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement.

Authors:  Frederik E Stuurman; Bastiaan Nuijen; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

2.  Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.

Authors:  Catia Marzolini; Rajith Rajoli; Manuel Battegay; Luigia Elzi; David Back; Marco Siccardi
Journal:  Clin Pharmacokinet       Date:  2017-04       Impact factor: 6.447

3.  CriticalSorb™ promotes permeation of flux markers across isolated rat intestinal mucosae and Caco-2 monolayers.

Authors:  D J Brayden; V A Bzik; A L Lewis; L Illum
Journal:  Pharm Res       Date:  2012-05-26       Impact factor: 4.200

Review 4.  pH- and ion-sensitive polymers for drug delivery.

Authors:  Takayuki Yoshida; Tsz Chung Lai; Glen S Kwon; Kazuhiro Sako
Journal:  Expert Opin Drug Deliv       Date:  2013-08-09       Impact factor: 6.648

5.  Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods.

Authors:  Li Key Yeo; Temidayo O B Olusanya; Cheng Shu Chaw; Amal Ali Elkordy
Journal:  Pharmaceutics       Date:  2018-10-13       Impact factor: 6.321

Review 6.  Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years.

Authors:  Zhiguo Li; Minting Liu; Lingjie Ke; Li-Juan Wang; Caisheng Wu; Cheng Li; Zibiao Li; Yun-Long Wu
Journal:  Nanoscale Adv       Date:  2021-08-10

7.  Mechanism of mucosal permeability enhancement of CriticalSorb® (Solutol® HS15) investigated in vitro in cell cultures.

Authors:  Saif Shubber; Driton Vllasaliu; Cyril Rauch; Faron Jordan; Lisbeth Illum; Snjezana Stolnik
Journal:  Pharm Res       Date:  2014-09-05       Impact factor: 4.200

8.  Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy.

Authors:  Keun Sang Oh; Kyungim Kim; Byeong Deok Yoon; Hye Jin Lee; Dal Yong Park; Eun-Yeong Kim; Kiho Lee; Jae Hong Seo; Soon Hong Yuk
Journal:  Int J Nanomedicine       Date:  2016-03-16

9.  Solutol HS15 based binary mixed micelles with penetration enhancers for augmented corneal delivery of sertaconazole nitrate: optimization, in vitro, ex vivo and in vivo characterization.

Authors:  Nihal Farid Younes; Sally Adel Abdel-Halim; Abdelhalim I Elassasy
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.